UnitedHealthcare Tightens Reimbursement on Five Lab Tests

UnitedHealthcare is tightening how it pays for lab work. According to Becker's Hospital Review, the insurer is rolling out new reimbursement policies covering five categories of tests: allergen testing, liver fibrosis testing, in vitro chemotherapy sensitivity assays, testosterone blood tests, and vitamin B12 testing.

The limits reach across the insurer's book of business, including commercial, ACA exchange, Medicare Advantage, and Medicaid plans. Most of the policies take effect Sept. 1 for commercial, exchange, and Medicare Advantage members, Becker's reports.

The move fits a broader payer push to curb spending on tests UnitedHealthcare views as overused or low-value, shifting more documentation and financial risk onto labs and ordering physicians. In practice, providers should expect more claim denials and prior-authorization friction for these tests unless orders are clearly supported by clinical criteria. Labs, health systems, and physician groups will need to review the specific policy language and adjust ordering and billing workflows before the effective dates to avoid unpaid claims.